22 research outputs found

    Immunohistochemical analysis of whole knee joints from 60 day-old male mice by use of anti-5-HT<sub>2A</sub>R and 5-HT<sub>2B</sub>R antibodies.

    No full text
    <p>(A-C) Sections of the frontal knee joints were stained with toluidine blue, and cartilage tissues showed metachromatic staining. The areas surrounded by the boxes are enlarged in ā€œBā€ (articular cartilage tissues) and ā€œCā€ (growth plate). (D-H) In the low-power magnification view of the knee joint stained with anti-5-HT<sub>2A</sub>R (D) the areas surrounded by the boxes are enlarged (E, H). Images of ā€œEā€ and ā€œFā€ represent articular cartilage tissues (E) and the growth plate (F). A serial section was stained with a non-immune antibody as a negative control, and images of the same areas as seen in ā€œEā€ and ā€œFā€ are shown in ā€œGā€ and ā€œMā€, respectively. The immunoreactivity for 5-HT<sub>2A</sub>R was detected in cells from the proliferating to prehypertrophic regions of the growth plate. (I-M) The knee joint stained with anti-5-HT<sub>2B</sub>R. In the low-power-magnification view (I), the areas indicated by the boxes are enlarged in ā€œJā€ and ā€œKā€. Images in ā€œJā€ and ā€œKā€ represent articular cartilage tissues (J) and the growth plate (K). Images in ā€œLā€ and ā€œMā€ represent the same areas as seen in ā€œJā€ and ā€œK,ā€ respectively, in a serial section stained with a non-immune antibody as a negative control. The immunoreactivity for 5-HT<sub>2B</sub>R was detected in the surface layer of articular cartilage tissues. The sizes of scale bars are indicated.</p

    Human forward (F) and reverse (R) primers used for real-time PCR.

    No full text
    <p>Human forward (F) and reverse (R) primers used for real-time PCR.</p

    Real-time RT-PCR analysis of <i>COL2A1</i>, <i>ACAN</i>, and <i>CCN2</i> mRNAs in HCS-2/8 cells treated with BW723C86, an agonist of 5-HT<sub>2B</sub>R.

    No full text
    <p>(A) After HCS-2/8 cells had reached confluence, they were treated with BW723C86 at a concentration of 10 Ī¼M for 12 h. Then, total RNA was collected; and real-time RT-PCR analysis was performed. The amounts of these mRNAs were normalized to that amount of <i>GAPDH</i> mRNA. The graphs show the expression levels of (a) <i>COL2a1</i>, (b) <i>ACAN</i>, (c) <i>CCN2</i> after incubation with (n = 6) or without BW723C86 (n = 6). (B) HCS-2/8 cells were treated with BW723C86 at a concentration of 10 Ī¼M for 24 h. The graphs show the expression levels of (a) <i>COL2a1</i>, (b) <i>ACAN</i>, (c) <i>CCN2</i> after incubation with (n = 3) or without BW723C86 (n = 3). In all graphs, the ordinate indicates the relative ratio with respect to untreated sample (ratio = 1.0), and bars represent mean and standard deviation. The data were analyzed by Student <i>t</i>-test, and <i>p</i> < 0.05 (*) was considered significant.</p

    Activation of Ca<sup>2+</sup> influx, and phosphorylation of Akt and PKCs in HCS-2/8 cells stimulated with 5-HT, and agonists of 5-HT<sub>2A</sub>R and 5-HT<sub>2B</sub>R.

    No full text
    <p>(A) After HCS-2/8 cells had reached sub-confluence, the cells were pre-treated with Fluo-4AM (final concentration; 3 mmol/l) in a recording medium at 37Ā°C. After 20 min, the culture medium was replaced with recording medium without Fluo-4AM; and these cells were then treated with 5-HT (10 Ī¼M), NBOH-2C-CN (100 Ī¼M) or BW723C86 (10 Ī¼M) for 1 min. Photographs of the cells were taken under a fluorescence microscope (upper panels). The same field was visualized by phase-contrast microscopy (lower panels). The bar represents 50 Ī¼m. (B; a) Time course of fluorescence intensity measured by using a Fluo-4 AM in HCS-2/8 cells treated with 5-HT, NBOH-2C-CN or BW723C86. The ordinate indicates the ratio of fluorescence intensity with respect to untreated sample (ratio = 1.0). Arrow indicates stimulation point (time = 0). (b) Bar graph shows the ratio of fluorescent intensity of each group at 60 seconds after treatment (dotted line in panel ā€œaā€). Results are presented as the mean and standard deviations of 8 independent cultures and analyzed by Bonferroniā€™s test, and p < 0.05 (*) was considered significant. (C-F) After HCS-2/8 cells had reached confluence, the cells were treated with 5-HT or the indicated agonist at the final concentrations shown. After 5 min, cell lysates were prepared; and Western blot analysis was then performed with antibodies recognizing the indicated proteins. (C) The level of phosphorylated Akt (n = 3) was increased by the treatment with NBOH-2C-CN (10 Ī¼M and 100 Ī¼M) and (D) PKCĪµ (n = 4) and (E) PKCĪ¶ (n = 3) phosphorylation levels were increased by the treatment with BW723C86 (10 Ī¼M). (F) The level of phosphorylated PKCĪ± (n = 3) showed no change. The total amounts of conventional PKCĪ± (PKCĪ±), novel PKCĪµ (PKCĪµ), and atypical PKCĪ¶ (PKCĪ¶) remained unchanged by any treatment. The graph indicates relative densitometry (untreated control = 1.0; dotted line) from 3 measurements and analyzed by Dunnettā€™s test, and <i>p</i> < 0.05 (*) was considered significant.</p

    Protein production of CCN2 regulated by 5-HT signaling via 5-HT<sub>2A</sub>R and 5-HT<sub>2B</sub>R.

    No full text
    <p>HCS-2/8 cells were grown until they had reached confluence. (A) The cells were treated with vehicle control (PBS and/or DMSO), 5-HT, ritanserin alone, the combination of 5-HT and ritanserin, SB204741 alone, or the combination of 5-HT and SB204741 at the indicated dose. Cell lysates were prepared 24 h later, and Western blot analysis was performed with anti-CCN2 and Ī²-actin antibodies. The graph indicates relative densitometry to untreated controls (ratio = 1.0; dotted line) from 5 independent cultures and analyzed by Bonferroniā€™s test, and <i>p</i> < 0.05 (*) was considered significant. (B) HCS-2/8 cells were treated with 5-HT alone (10 Ī¼M), NBOH-2C-CN (10 Ī¼M or 100 Ī¼M) or BW723C86 (1 Ī¼M or 10 Ī¼M) for 24 h. Then cell lysates were prepared, and Western blot analysis was performed. Relative densitometry (untreated control = 1.0; dotted line) from 5 independent cultures are presented and analyzed by Bonferroniā€™s test, and <i>p</i> < 0.05 (*) was considered significant. (C) HCS-2/8 cells were treated with 5-HT at the concentration of 10 Ī¼M for 24 h, and the cell culture supernatant and cell layer fraction were harvested. Quantification of 5-HT was performed by using an ELISA system. The concentration of 5-HT produced by HCS-2/8 cells was determined by subtracting the 5-HT concentration in fresh media from that in conditioned media. Results are presented as the mean and standard deviations of 3 independent cultures and analyzed by Bonferroniā€™s test, and <i>p</i> < 0.05 (*) was considered significant. (D) HCS-2/8 cells were treated with 5-HT at the concentration of 10 and 50 Ī¼M for 24 h, and Western blot analysis was performed. The graph indicates relative densitometry to untreated controls (ratio = 1.0; dotted line) from 3 measurements and analyzed by Dunnettā€™s test, and there was no significant difference.</p

    Real-time RT-PCR analysis of <i>COL2A1</i>, <i>ACAN</i>, and <i>CCN2</i> mRNAs in HCS-2/8 cells treated with the combination of 5-HT and SB204741, an antagonist of 5-HT<sub>2B</sub>R or retanserin, an antagonist of 5-HT<sub>2A</sub>R.

    No full text
    <p>(A) HCS-2/8 cells were grown until they had reached confluence. Then, the cells were treated with 5-HT (10 Ī¼M), ritanserin, an antagonist of 5-HT<sub>2A</sub>R (100 Ī¼M), SB204741, an antagonist of 5-HT<sub>2B</sub>R (30 Ī¼M) or the combination of 5-HT and SB206553 or ritanserin. After 12 h, total RNA was collected; and real-time RT-PCR analysis was then performed. The amounts of these mRNAs were normalized to that amount of <i>GAPDH</i> mRNA. The graphs show the expression levels of (a) <i>COL2a1</i>, (b) <i>ACAN</i>, (c) <i>CCN2</i> mRNAs in HCS-2/8 cells treated with vehicle control (PBS and/or DMSO, n = 4), 5-HT (n = 4), ritanserin alone (n = 3), the combination of 5-HT and ritanserin (n = 3), SB204741 alone (n = 4), or the combination of 5-HT and SB204741 (n = 4). (B) HCS-2/8 cells were treated with 5-HT, ritanserin, SB204741, or the combination of 5-HT and SB206553 or ritanserin for 24 h. The graphs show the expression levels of (a) <i>COL2a1</i>, (b) <i>ACAN</i>, (c) <i>CCN2</i> in HCS-2/8 cells treated with vehicle control (PBS and/or DMSO, n = 4), 5-HT (n = 4), ritanserin alone (n = 4), the combination of 5-HT and ritanserin (n = 4), SB204741 alone (n = 4), or the combination of 5-HT and SB204741 (n = 4). In all graphs, the ordinate indicates fold induction with respect to control sample (ratio = 1.0), and bars represent mean and standard deviation. The data were analyzed by Tukeyā€™s test for multiple comparisons, and <i>p</i> < 0.05 (*), <i>p</i> < 0.01 (**) was considered significant.</p

    Activation of MAPKs in HCS-2/8 cells treated with 5-HT or agonist of each 5-HT<sub>2</sub> receptor and rescue effect of inhibitors of ERK1/2 and JNK on the BW723C86-decreased CCN2 production.

    No full text
    <p>(A) HCS-2/8 cells were grown until they had reached confluence. Then, the cells were treated with 5-HT, NBOH-2C-CN or BW723C86 at the indicated concentrations. After 15 min, cell lysates were prepared; and Western blot analysis was performed with the antibodies against the indicated proteins. The levels of phosphorylated ERK1/2 and JNK were increased by the treatment with BW723C86 at a concentration of 10 Ī¼M. In contrast, the levels of phosphorylated p38 MAPK were increased by the treatment with NBOH-2C-CN at the concentrations of 10 Ī¼M and 100 Ī¼M. (B) HCS-2/8 cells were grown until they had reached confluence. Then, when the cells were treated with 5-HT (10 Ī¼M) or BW723C86 (10 Ī¼M), PD98059 (MEK1 inhibitor; 50 Ī¼M) or SP600125 (JNK inhibitor; 50 Ī¼M) was applied to the cultures simultaneously. After 24 h, the cell lysates were prepared; and Western blot analysis was performed with anti-human CCN2 rabbit serum and Ī²-actin antibody. When HCS-2/8 cells were treated with 5-HT, PD98059 or SP600125 had no effects. In contrast, when the cells were treated with BW723C86, CCN2 production was rescued by either PD98059 or SP600125. The graphs give the results of Western blotting using anti-CCN2 antibody and quantified by densitometric analysis, with normalization by the levels of Ī²-actin. The ordinate indicates the fold change relative to untreated controls (ratio = 1.0; dotted line). The graph indicates relative densitometry (untreated control = 1.0; dotted line) from 6 independent cultures and analyzed by Bonferroni's test, and <i>p</i> < 0.05 (*) was considered significant.</p

    Effect of 5-HT on the gene expression and protein production of 5-HT<sub>2</sub> receptor in HCS-2/8 cells.

    No full text
    <p>(A) After HCS-2/8 cells had reached confluence, they were treated with 5-HT at a concentration of 10 Ī¼M for 24 h. Then, total RNA was isolated and real-time RT-PCR analysis was performed by using specific primers for GAPDH, TpH-1, 5-HT<sub>2A</sub>R, 5-HT<sub>2B</sub>R and 5-HT<sub>2C</sub>R. The ordinate indicates the relative ratio with respect to GAPDH expression, and data represents mean and standard deviation of culture with (n = 4) or without 5-HT (n = 4). The gene expressions levels of <i>5-HT</i><sub><i>2A</i></sub><i>R</i>, <i>5-HT</i><sub><i>2B</i></sub><i>R</i>, and <i>TpH-1</i> were confirmed in HCS-2/8 cells, whereas 5-HT<sub>2C</sub>R was not detected (ND). In addition, these gene expressions were not affected by the treatment with 5-HT. (B) After HCS-2/8 cells had reached confluence, they were treated with 5-HT for 24 h. Then, Western blot analysis was performed by using antibodies recognizing the indicated proteins. The apparent molecular weights of 5-HT<sub>2A</sub>R were 75 kDa (arrow) and 50 kDa (arrowhead). The major band of 5-HT<sub>2B</sub>R indicated a molecular weight 55 kDa (arrow), and minor bands were found at 30 kDa (arrowheads). The major band of 5-HTT was at 53 kDa (arrow), and a minor band at 75 kDa (arrowhead). Exogenous 5-HT added had no effect on the production of these proteins. Histone H3 was used as a loading control.</p

    miRNA expression signature in DPCs and in periodontal ligament-derived cells (PDLCs).

    No full text
    <p>A) Clustering analysis of SP and MP cells from DPCs and PDLCs. B) A comparative scatter plot analysis of miRNA profiles in MP from DPCs and PDLCs. C) A comparative scatter plot analysis of miRNA profiles in SP from DPCs and PDLCs. Red line shows variations of 2 fold (upper line) and 1/2 fold (lower line) change. D) Quantification of miR-720 expression level in sorted MP and SP cells. Results are the average (Ā±SD) of a single experiment run in triplicate. *** P<0.001, unpaired <i>t</i>-test, compared to MP.</p
    corecore